BSc (Hons), PhD, MRSC, EPA, CPA, PAL,
Tony is a specialist in handling matters relating to pharmaceutical inventions, including new chemical entities, pharmaceutical formulations and drug delivery technologies, new medical uses of known therapeutic agents, and medical diagnostic kits. He also works with clients in the broader area of chemistry, with a particular interest in chemical processes and novel materials. He works with a wide range of clients, from university spin-outs to multi-national companies, providing him with a valuable insight into the needs of businesses at each stage of development.
Tony has extensive experience in patent drafting, European and global patent prosecution, freedom-to-operate and patentability analyses, due diligence, portfolio management, and attacking and defending patents via the European opposition and appeals procedure. He has also handled the filing of numerous applications for supplementary protection certificates (SPCs) throughout Europe.
With a particular focus on the needs of businesses operating in the pharmaceutical sector, Tony has worked closely with his clients in order to balance their IP strategy with the demands of the associated regulatory procedures. He has delivered talks and seminars on wide-ranging topics, and to audiences as far afield as India and the US, and across Scandinavia. Tony is a frequent visitor to Sweden, where he assists many clients whilst working from Potter Clarkson’s Stockholm office.
Prior to joining the profession, Tony obtained a first class degree in Chemistry with Biosciences, before completing his doctorate in Synthetic Organic Chemistry, both at Cardiff University. Tony's doctoral research was focused on heterocyclic synthesis and product purification, and has been the subject of several patents and academic papers. His research was funded by Syngenta Ltd, a multi-national agrochemicals company, and his final year presentation was awarded their first prize.
Following this, Tony undertook a period of postdoctoral research at the University of Nottingham (funded by Cancer Research UK), developing novel Polo-like kinase inhibitors as potential therapeutic agents, before joining Potter Clarkson in 2007.
Tony qualified as a European Patent Attorney in 2012, and as a Chartered Patent Attorney shortly thereafter. In 2017, he qualified as a Patent Attorney Litigator (PAL) and was awarded a Higher Courts Litigation Certificate, allowing him to conduct litigation in the High Court and the Court of Appeal, in addition to having a right of audience in the Intellectual Property Enterprise Court (IPEC).
Tony is listed as a Rising IP Star by Managing Intellectual Property for 2018.